Aura Biosciences, Inc.
AURA
$6.55
$0.081.24%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 0.69% | 4.00% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -1.45% | 4.42% | |||
| Operating Income | 1.45% | -4.42% | |||
| Income Before Tax | 1.80% | -6.41% | |||
| Income Tax Expenses | 166.67% | -25.00% | |||
| Earnings from Continuing Operations | 1.69% | -6.38% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 1.69% | -6.38% | |||
| EBIT | 1.45% | -4.42% | |||
| EBITDA | 1.45% | -4.46% | |||
| EPS Basic | 15.06% | -5.99% | |||
| Normalized Basic EPS | 15.13% | -6.01% | |||
| EPS Diluted | 15.06% | -5.99% | |||
| Normalized Diluted EPS | 15.13% | -6.01% | |||
| Average Basic Shares Outstanding | 15.74% | 0.38% | |||
| Average Diluted Shares Outstanding | 15.74% | 0.38% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||